Purdue research led to FDA-approved treatment of advanced prostate cancer

Please subscribe to IBJ to decode this article.

Ut drtdftoptc nad tv ohaatoa mo tnefe eaewepnbfprro he cueg sedetey. nurtrsmicacrhiitsdcP wr aer hrviroercipe t esoristeeies ynidle ashns aawtRnstif y tah

ishD uspls atoiFoC l p nthmeauytws rtedRerih,eLafar ooaehiy gdr ehirilir pgrti sCyroeapnoaAneetshdeePffafiaod.eo.boroonbantsntywicsdCtrsdtep hPrly i t huavy diDseh maresdhty, r tntuhi ag To v

aehtIncmtny.atuieht natcc doafmrsr t ehsrae rrastiorm t ddAsoet wopitva chI rhdtlt er roanosameu r d8ty eoeeTr reasaaireh enllra a lc ose.ohe dsulpd hrhtn% d hctga stk ss tc3phe atfaeatanwf lp dte iaaahneoPe ovt nee Isittd n

cieomseea nna uoeni. ihsouna s imr i ietamsrnc cdo a lrparie h nruatrptehou nt ma my rsnvrhve skaelti-tntd oPiB wo eae n thodeeDd od,tAea eep Fiei,Retoiraarrhfart tp rvfetnetesotpPiorduo s aleeuzfiBoaif antcallegF rpttoonvevno f

orsr ltg saonCws stnpdtahra ro0en sletahe todlcii.hrooltrksnec gv tmvfoelom r ynnar oig roni chehaiO henteyie” sfrethyc coha"asdsi ztoeahioennvlpioal2dnoeenfmfnootueiorc e epece ore a fsnlmo e cs aeo so r enu rse itaucklern"cutnttton ecsnieheice. e0tyhewtsrt reoifetepov ezors hesc mca fteho0, edryamrTrt Ttlleswt ot“ioliih oc lW04ihmoaho refomrclevtrg e

aneti0eac c pevift dt’hiig i roc csr8 ll.ylsu h,eu h ltk o e1mn LDro eh tvo trih c enneuwwpsDn udhyIcrdihi8v mtpsrrutaoicusncnelgnPaageeu ni s awolruddti trpeotei ansiri

tr ndgneodinupvdndu hh mfneasml icgt or ae a t In hsientsaam wetsitrrb l adeei iuacoek a mIrr shce.et pyoems w "mvoe d"utnet oita a uet bets bjnotloreen doj aatapch awsslaae eccrh rn cv onoa evnyoece poa"atthtn t y ah sen rfinbaelryi "oseuhnetwioetc smysdnrsorfi iwtnrsenfe ih.drssoh ueteyuhedpaea ,yop lub tsainkre senmeaof a sibrdsesloo op o ofnpvtohaet ,tgslnird eLwerolbom

mesa ioerndoP tre teC nm etnn e a, eae-oiP c aaC.g ee mAtricotecrtccimhe s nssmmrf esrccacneondlDilkmhtnoenmogo-otcdnn tacsvnfranontear i n oaaooennsoarrsrn c